Dr. Brian Furukawa, MD

Pulmonary Disease Temple, TX Male
NPI: 1457563231
Total Payments
$174,582
2024 Payments
$905.15
Companies
14
Transactions
233
Medicare Patients
1,328
Medicare Billing
$187,585

Payment Breakdown by Category

Consulting$98,989 (56.7%)
Other$35,434 (20.3%)
Travel$27,063 (15.5%)
Food & Beverage$6,342 (3.6%)
Education$6,174 (3.5%)
Research$566.40 (0.3%)
Gifts$13.57 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $98,989 37 56.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $34,684 21 19.9%
Travel and Lodging $27,063 67 15.5%
Food and Beverage $6,342 96 3.6%
Education $6,174 4 3.5%
Honoraria $750.00 1 0.4%
Unspecified $566.40 6 0.3%
Gift $13.57 1 0.0%

Payments by Type

General
$174,016
227 transactions
Research
$566.40
6 transactions

Top Paying Companies

Company Total Records Latest Year
Insmed, Inc. $88,838 113 $0 (2024)
Veran Medical Technologies, Inc. $42,554 49 $0 (2021)
US ENDOSCOPY $19,518 12 $0 (2023)
Intuitive Surgical, Inc. $16,202 22 $0 (2023)
AstraZeneca Pharmaceuticals LP $2,148 1 $0 (2021)
Pinnacle Biologics, Inc $1,845 13 $0 (2023)
CSA Medical, Inc $1,603 2 $0 (2018)
Ethicon Inc. $1,025 9 $0 (2021)
STERIS CORPORATION $555.46 6 $0 (2024)
Olympus America Inc. $97.41 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $905.15 9 Insmed, Inc. ($566.40)
2023 $24,367 29 Insmed, Inc. ($19,570)
2022 $51,265 55 Insmed, Inc. ($31,976)
2021 $42,156 54 Insmed, Inc. ($24,241)
2020 $4,964 15 Veran Medical Technologies, Inc. ($3,397)
2019 $23,364 41 Insmed, Inc. ($11,193)
2018 $16,016 15 Veran Medical Technologies, Inc. ($15,116)
2017 $11,545 15 Veran Medical Technologies, Inc. ($10,842)

All Payment Transactions

233 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
08/22/2024 Polarean, Inc. XENOVIEW (Drug) Food and Beverage Cash or cash equivalent $76.88 General
Category: Respiratory
08/19/2024 Olympus America Inc. — Food and Beverage In-kind items and services $97.41 General
05/28/2024 STERIS CORPORATION truFreeze (Device) Food and Beverage In-kind items and services $164.46 General
Category: Gastroenterology
05/23/2024 Insmed, Inc. Arikayce (Drug) — In-kind items and services $258.77 Research
Study: A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact • Category: Respiratory
05/23/2024 Insmed, Inc. Arikayce (Drug) — In-kind items and services $140.62 Research
Study: A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact • Category: Respiratory
05/23/2024 Insmed, Inc. Arikayce (Drug) — In-kind items and services $66.71 Research
Study: A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact • Category: Respiratory
05/23/2024 Insmed, Inc. Arikayce (Drug) — In-kind items and services $39.68 Research
Study: A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact • Category: Respiratory
05/23/2024 Insmed, Inc. Arikayce (Drug) — In-kind items and services $30.31 Research
Study: A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact • Category: Respiratory
05/23/2024 Insmed, Inc. Arikayce (Drug) — In-kind items and services $30.31 Research
Study: A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact • Category: Respiratory
11/24/2023 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $1,006.00 General
Category: Respiratory
10/10/2023 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $13.00 General
Category: SURGERY
09/21/2023 Insmed, Inc. — Consulting Fee Cash or cash equivalent $485.00 General
09/16/2023 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Travel and Lodging In-kind items and services $190.97 General
Category: SURGERY
09/14/2023 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $2,668.00 General
Category: Respiratory
09/14/2023 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $121.47 General
Category: Respiratory
09/13/2023 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Travel and Lodging In-kind items and services $6.00 General
Category: SURGERY
08/01/2023 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $17.61 General
Category: SURGERY
07/18/2023 Pinnacle Biologics, Inc Photofrin (Drug) Food and Beverage Cash or cash equivalent $90.63 General
Category: Oncology
07/17/2023 Pinnacle Biologics, Inc Photofrin (Drug) Food and Beverage Cash or cash equivalent $66.17 General
Category: Oncology
06/22/2023 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $4,123.00 General
Category: Respiratory
06/22/2023 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $970.00 General
Category: Respiratory
06/22/2023 Insmed, Inc. Arikayce (Drug) Travel and Lodging In-kind items and services $619.00 General
Category: Respiratory
06/22/2023 Insmed, Inc. Arikayce (Drug) Travel and Lodging In-kind items and services $617.72 General
Category: Respiratory
06/22/2023 Insmed, Inc. Arikayce (Drug) Travel and Lodging In-kind items and services $581.28 General
Category: Respiratory
06/22/2023 Insmed, Inc. Arikayce (Drug) Travel and Lodging In-kind items and services $211.63 General
Category: Respiratory
123…10»

Research Studies & Clinical Trials

Study Name Company Amount Records
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact Insmed, Inc. $566.40 6

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 615 799 $538,865 $66,323
2022 10 227 301 $58,933 $31,245
2021 8 176 296 $44,350 $35,763
2020 13 310 460 $245,564 $54,254
Total Patients
1,328
Total Services
1,856
Medicare Billing
$187,585
Procedure Codes
52

All Medicare Procedures & Services

52 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 74 137 $27,537 $12,380 45.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 94 152 $31,768 $10,757 33.9%
99291 Critical care, first 30-74 minutes Facility 2023 30 55 $29,425 $8,971 30.5%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 40 40 $15,960 $5,236 32.8%
31629 Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope Facility 2023 26 29 $52,113 $3,366 6.5%
31653 Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes Facility 2023 17 17 $44,710 $3,039 6.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 23 27 $7,560 $2,903 38.4%
31652 Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes Facility 2023 20 21 $55,230 $2,653 4.8%
31628 Biopsy of lobe of lung using an endoscope, 1 lobe Facility 2023 38 40 $44,920 $2,554 5.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 24 41 $5,699 $2,483 43.6%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 16 16 $6,272 $2,158 34.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 20 20 $5,340 $1,990 37.3%
32555 Aspiration of fluid from chest cavity using imaging guidance Facility 2023 18 23 $47,736 $1,929 4.0%
31627 Computer-assisted image-guided navigation of lung airways using an endoscope Facility 2023 20 21 $82,572 $1,518 1.8%
31624 Irrigation and suction of lung airways to obtain cells using an endoscope Facility 2023 54 55 $51,095 $1,409 2.8%
31654 Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound Facility 2023 24 26 $21,658 $1,306 6.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 16 17 $2,414 $756.45 31.3%
99152 Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes Facility 2023 50 50 $4,300 $466.89 10.9%
31632 Biopsy of lobe of lung using an endoscope, each additional lobe Facility 2023 11 12 $2,556 $446.52 17.5%
99291 Critical care, first 30-74 minutes Facility 2022 28 71 $17,692 $12,642 71.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 28 29 $7,815 $4,584 58.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 26 45 $6,156 $4,229 68.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 30 38 $6,117 $3,053 49.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 29 30 $6,163 $2,263 36.7%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 13 13 $5,187 $1,819 35.1%
123»

About Dr. Brian Furukawa, MD

Dr. Brian Furukawa, MD is a Pulmonary Disease healthcare provider based in Temple, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1457563231.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Furukawa, MD has received a total of $174,582 in payments from pharmaceutical and medical device companies, with $905.15 received in 2024. These payments were reported across 233 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($98,989).

As a Medicare-enrolled provider, Furukawa has provided services to 1,328 Medicare beneficiaries, totaling 1,856 services with total Medicare billing of $187,585. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.

Practice Information

  • Specialty Pulmonary Disease
  • Other Specialties Pulmonary Disease
  • Location Temple, TX
  • Active Since 05/04/2007
  • Last Updated 10/11/2022
  • Taxonomy Code 207RP1001X
  • Entity Type Individual
  • NPI Number 1457563231

Products in Payments

  • Arikayce (Drug) $81,575
  • Spin (Device) $40,057
  • TruFreeze (Device) $11,764
  • Da Vinci Surgical System (Device) $9,902
  • truFreeze (Device) $7,840
  • DAVINCI XI (Device) $3,000
  • ION (Device) $3,000
  • SPiN Thoracic Navigation System, 120V, 60Hz (Device) $2,497
  • TAGRISSO (Drug) $2,148
  • Photofrin (Drug) $1,845
  • Monarch Platform (Device) $1,025
  • DA VINCI SP (Device) $300.00
  • XENOVIEW (Drug) $76.88
  • Pulmonx Endobronchial Valve EBV (Device) $58.94
  • General - Pulmonary (Device) $51.99
  • TRUFREEZE (Device) $19.12
  • AERO Stent & del system (Device) $8.73

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pulmonary Disease Doctors in Temple

Dr. Andrew Kim, Md, Ms, MD, MS

Pulmonary Disease — Payments: $3,935

Pulmonary Disease $3,935

Jonathan Ram, Md, MD

Pulmonary Disease — Payments: $3,212

Pulmonary Disease $3,212

Jemina Morales, M.d, M.D

Pulmonary Disease — Payments: $782.83

Pulmonary Disease $782.83

Dr. Richard Beckendorf, M.d, M.D

Pulmonary Disease — Payments: $380.11

Pulmonary Disease $380.11

Sushmita Shrestha, M.b.b.s, M.B.B.S

Pulmonary Disease — Payments: $246.05

Pulmonary Disease $246.05

Dr. Nithin Kesireddy, Md, MD

Pulmonary Disease — Payments: $239.56

Pulmonary Disease $239.56